Thiogenesis Therapeutics Market Cap

Thiogenesis Therapeutics has a market cap or net worth of CAD 25.03 million as of January 21, 2025. Its market cap has decreased by -0.91% in one year.

Market Cap

25.03M

Enterprise Value

20.88M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

0.55

Market Cap Chart

Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 25.03M, an increase of 79.36%. That is a compound annual growth rate of 23.41%.

Market Cap History

Date	Market Cap	% Change
Jan 21, 2025	25.03M	-8.33%
Dec 31, 2024	27.31M	-18.31%
Dec 29, 2023	33.43M	48.30%
Dec 30, 2022	22.54M	61.52%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Green Thumb Industries	2.54B
Curaleaf Holdings	1.63B
WELL Health Technologies	1.63B
dentalcorp Holdings	1.54B
Trulieve Cannabis	1.37B
Sienna Senior Living	1.25B
Cronos Group	1.10B
Extendicare	863.05M

Market Cap Rankings